Methods for the detection of analytes in small-volume blood samples

Patent metadata

Field	Value
Publication number	US-11802882-B2
Application number	US-201816222845-A
Country	US
Kind code	B2
Filing date	Dec 17, 2018
Priority date	Nov 14, 2006
Publication date	Oct 31, 2023
Grant date	Oct 31, 2023

Abstract

This invention is in the field of medical devices. Specifically, the present invention provides portable medical devices that allow detection of analytes from a biological fluid. The methods and devices are particularly useful for providing point-of-care testing for a variety of medical applications.

First claim

What is claimed is:

1. A microfluidic cartridge for carrying out an assay to detect an analyte in a bodily fluid sample, comprising:
a sample collection unit comprising a sample collection well for receiving the bodily fluid sample;
an assay unit in fluid communication with the sample collection well, wherein the assay unit comprises a reactant chamber having a reaction site with a reactant immobilized on the reaction site and configured to react with the analyte in the bodily fluid sample to generate a colored product having an absorbance spectrum; and
a light source comprising a luminescent paint coated on the reaction site, wherein a spectrum of light emitted from the luminescent paint has at least one wavelength that is a function of the absorbance spectrum.

2. The microfluidic cartridge of claim 1 , wherein the sample collection unit further comprises a metering channel in fluid communication with the sample collection well, the metering channel configured to collect a predetermined portion of the bodily fluid sample to be assayed, wherein the assay unit is in fluid communication with the sample collection well by means of the metering channel, and wherein the predetermined portion of the bodily fluid sample has a volume of about 10 to about 50 microliters.

3. The microfluidic cartridge of claim 2 , wherein the metering channel comprises a metering element configured to close off fluidic connection between the sample collection well and the metering channel to prevent a volume of the bodily fluid sample larger than the predetermined portion of the bodily fluid sample from being assayed.

4. The microfluidic cartridge of claim 3 , wherein the metering element is a pin that is movable so as to close off fluidic connection between the sample collection well and the metering channel.

5. The microfluidic cartridge of claim 1 , wherein the reactant chamber comprises a cylindrical configuration.

6. The microfluidic cartridge of claim 1 , wherein the reactant chamber is at least partially transparent such that light can be transmitted through the reactant chamber.

7. The microfluidic cartridge of claim 6 , wherein the reactant chamber comprises functionalized glass.

8. The microfluidic cartridge of claim 2 , further comprising a dilution chamber in fluid communication with the metering channel of the sample collection unit, wherein the dilution chamber is configured to store a diluent.

9. The microfluidic cartridge of claim 1 , further comprising a reagent chamber for storing a reagent for carrying out the assay to detect the analyte, wherein the reagent chamber is in fluid communication with the reactant chamber of the assay unit.

10. The microfluidic cartridge of claim 9 , wherein the reagent chamber stores a reagent selected from a wash buffer, an enzyme substrate, a dilution buffer, a conjugate, an enzyme-labeled conjugate, a DNA amplifier, a sample diluent, a wash solution, a detergent, a polymer, a chelating agent, an albumin-binding reagent, an enzyme inhibitor, an enzyme, an anticoagulant, a red-cell agglutinating agent, and an antibody.

11. The microfluidic cartridge of claim 1 , wherein the microfluidic cartridge comprises all reagents necessary to perform the assay to detect the analyte.

12. The microfluidic cartridge of claim 1 , wherein the microfluidic cartridge comprises a length of about 7 cm to about 30 cm, and a width of about 5 cm to about 30 cm.

13. The microfluidic cartridge of claim 1 , further comprising a plurality of reactant chambers of a plurality of assay units, and wherein each reactant chamber of the plurality of reactant chambers comprises a reaction site with a different reactant immobilized on the reaction site for reacting with a different analyte in the bodily fluid sample.

14. A point-of-care system for detecting an analyte in a bodily fluid sample, comprising:
a microfluidic cartridge, comprising:
a sample collection unit comprising a sample collection well for receiving the bodily fluid sample,
an assay unit in fluid communication with the sample collection well, wherein the assay unit comprises a reactant chamber having a reaction site with a reactant immobilized on the reaction site and configured to react with the analyte in the bodily fluid sample to generate a colored product having an absorbance spectrum, and
a light source comprising a luminescent paint coated on the reaction site, wherein a spectrum of light emitted from the luminescent paint has at least one wavelength that is a function of the absorbance spectrum; and

a bench-top reader assembly configured to receive the microfluidic cartridge, wherein the bench-top reader assembly comprises:
one or more actuating elements that direct and control a flow of the bodily fluid sample from the sample collection unit to the assay unit of the microfluidic cartridge, and
a detector configured to detect an absorption of light of the at least one wavelength, wherein the absorption of light is indicative of the presence of the analyte.

15. The point-of-care system of claim 14 , wherein the reader assembly further comprises a controller configured to control the one or more actuating elements according to a protocol for conducting the assay to detect the analyte.

16. The point-of-care system of claim 15 , wherein the reader assembly further comprises a communication assembly for transmitting a signal detected by the detector to an external device for processing.

17. The point-of-care system of claim 14 , wherein the detector is an optical detector.

18. The point-of-care system of claim 14 , wherein the microfluidic cartridge further comprises a waste chamber in fluid communication with the reactant chamber, and wherein the reader assembly is further configured to direct flow of the bodily fluid sample from the reactant chamber to the waste chamber.

19. The point-of-care system of claim 14 , wherein the microfluidic cartridge further comprises a reagent chamber that stores a reagent for conducting the assay to detect the analyte, and
wherein the reader assembly is configured to direct flow of the reagent from the reagent chamber to the reactant chamber.

Assignees

• Labrador Diagnostics Llc

Inventors

• Gibbons Ian
• Roy Shaunak
• Ku Edmond

Classifications

• G01N33/92 Primary

  involving lipids, e.g. cholesterol {, lipoproteins, or their receptors (steroid hormones G01N33/743)} · CPC title

• B01L3/502707

  characterised by the manufacture of the container or its components · CPC title

• B01L3/502715 Primary

  characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces · CPC title

• B01L3/502753

  characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation · CPC title

• C12Q1/60

  involving cholesterol · CPC title